MacroGenics reported Q results with an EPS loss of $0.22 versus the Zacks consensus loss of $0.42, beating estimates by $0.20. The loss narrowed from $0.25 a year ago (improvement of $0.03), signaling modest operational improvement that could be viewed positively by investors.
MacroGenics reported Q results with an EPS loss of $0.22 versus the Zacks consensus loss of $0.42, beating estimates by $0.20. The loss narrowed from $0.25 a year ago (improvement of $0.03), signaling modest operational improvement that could be viewed positively by investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
